HCS Pharma in BioAsia-Taiwan Focus Symposium in Drug Discovery

We are really pleased to announce that we will be present in BioAsia-Taiwan and present our breakthrough technology BIOMIMESYS alongside our partners Molecular Devices (USA) and LumiSTAR Biotechnology (TW). We are 3 companies in 3 different continents unifying their strenghs to develop the best strategy to find new and more efficient treatment against long and complex diseases of our century such as cancer, neurodegenerative diseases (Alzheimer’s, Parkinson’s) or metabolic diseases.

We will present how we can change the paradigm in drug discovery to be more efficient to find new and more efficient drugs. It is a real pleasure to work with such amazing partners, with the best solution of cell imaging systems from Molecular Devices and with the open-mindset team from LumiSTAR Biotechnology. Using all cutting-edge technologies such as BIOMIMESYS, iPSCs, organs-on-chip and the best cell imaging systems, we are able to recreate in vitro healthy or diseased 3D microtissues with cells embeded in the right ExtraCellular Matrix (ECM) using BIOMIMESYS and perform phenotypic screening in high throughput. Using our 3D reconstructed microtissues, we are able to test libraries of compounds as if we test them in the real body.

Come in our Focus Symposium event on 27 July at 13.30 during BioAsia event to discuss how we will change the paradigm to find new and more efficient treatment for a better life.

『Pushing Frontiers in Drug Screening』
Time: 7/27 (Thu) 1:30 pm
Venue: Room 403, Hall 1, Nangang Exhibition Center

Focus Symposium jointly organized by LumiSTAR(TW), HCS Pharma (France) and Molecular Devices (USA)
Will bring you the most cutting-edge practical technology sharing: discuss iPSC high-throughput screening, Organ-on-chip, Extracellular Matrix and 3D organoids automation platform.

『Pushing Frontiers in Drug Screening』
時間：7/27 (四) 1:30 pm
地點：南港展覽館一館403室

由LumiSTAR(TW), HCS Pharma (France) 及Molecular Devices (USA) 聯合主辦的Focus Symposium
將為您帶來最前沿的實戰技術分享：探討iPSC高通量篩選、Organ-on-chip, Extracellular Matrix 及3D organoids 自動化平台。